205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.36%
Revenue growth under 50% of AMD's 26.40%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
15.92%
Gross profit growth at 50-75% of AMD's 30.66%. Martin Whitman would question if cost structure or brand is lagging.
75.90%
EBIT growth below 50% of AMD's 198.82%. Michael Burry would suspect deeper competitive or cost structure issues.
75.90%
Operating income growth under 50% of AMD's 251.56%. Michael Burry would be concerned about deeper cost or sales issues.
14.77%
Net income growth under 50% of AMD's 238.30%. Michael Burry would suspect the firm is falling well behind a key competitor.
-15.38%
Negative EPS growth while AMD is at 100.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-16.00%
Negative diluted EPS growth while AMD is at 100.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
50.74%
Share count expansion well above AMD's 1.15%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
51.98%
Diluted share count expanding well above AMD's 20.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-35.45%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
109.22%
OCF growth under 50% of AMD's 38859100.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
186.64%
FCF growth 50-75% of AMD's 282.17%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-48.19%
Negative 10Y revenue/share CAGR while AMD stands at 59.77%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
21.71%
5Y revenue/share CAGR at 75-90% of AMD's 25.38%. Bill Ackman would encourage strategies to match competitor’s pace.
-38.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
36.94%
10Y OCF/share CAGR above 1.5x AMD's 15.05%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
120.38%
5Y OCF/share CAGR at 50-75% of AMD's 185.30%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
8.97%
3Y OCF/share CAGR under 50% of AMD's 38.80%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
71.28%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
137.70%
5Y net income/share CAGR above 1.5x AMD's 58.74%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-45.79%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
127.57%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
59.18%
Positive 5Y equity/share CAGR while AMD is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-36.96%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-5.96%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-4.47%
Negative 5Y dividend/share CAGR while AMD stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-34.92%
Negative near-term dividend growth while AMD invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.66%
Firm’s AR is declining while AMD shows 12.15%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.11%
Inventory is declining while AMD stands at 0.76%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.81%
Asset growth well under 50% of AMD's 6.45%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-31.13%
We have a declining book value while AMD shows 4.22%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.48%
We’re deleveraging while AMD stands at 0.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.27%
Our R&D shrinks while AMD invests at 5.84%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.60%
We cut SG&A while AMD invests at 7.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.